Early Changes In B Cell Subsets Predict Risk Of Autoimmunity Following Combination Immune Checkpoint Blockade

ABSTRACT: We report changes in B cells in patients treated with combination immune checkpoint blockade (CCB; anti-CTLA4 and anti-PD1)

ORGANISM(S): Homo sapiens

PROVIDER: GSE104600 | GEO | 2017/11/29

SECONDARY ACCESSION(S): PRJNA413178

REPOSITORIES: GEO